IP Library Granted Patent US 9,150,872
Granted Patent B2
US 9,150,872 · App. 14/261,165 · Granted Oct 6, 2015

Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,150,872
App. No.
14/261,165
Granted
Oct 6, 2015
Kind
B2
Abstract

Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.

Claims (25)

1. A method for increasing a nicotinic alkaloid in a Nicotiana plant, comprising

introducing into a Nicotiana plant a vector comprising at least 21 consecutive nucleotides of a nucleotide sequence, wherein the nucleotide sequence is selected from the group consisting of:

(a) the nucleotide sequence set forth in SEQ ID NO: 4; and

(b) a nucleotide sequence that is at least 90% identical to the nucleotide sequence of SEQ ID NO: 4; and

wherein the 21 consecutive nucleotides are in sense orientation, antisense orientation, or both.

2. The method of claim 1 , further comprising overexpressing within the Nicotiana plant at least one of NBB1, A622, quinolate phospho-ribosyltransferase (QPT), putrescine-N-methyltransferase (PMT), and N-methylputrescine oxidase (MPO).

3. The method of claim 1 , further comprising overexpressing at least one transcription factor that positively regulates nicotinic alkaloid biosynthesis.

4. The method of claim 1 , further comprising suppressing the expression of at least one additional transcription factor that negatively regulates nicotinic alkaloid biosynthesis.

5. The method of claim 1 , wherein the nucleotide sequence comprises the nucleotide sequence set forth in SEQ ID NO: 4.

6. The method of claim 1 , wherein the nucleotide sequence comprises a nucleotide sequence that is at least 90% identical to the nucleotide sequence set forth in SEQ ID NO: 4.

7. The method of claim 1 , wherein the nucleotide sequence comprises a nucleotide sequence that is at least 95% identical to the nucleotide sequence set forth in SEQ ID NO: 4.

8. The method of claim 2 , wherein NBB 1 is overexpressed.

9. The method of claim 2 , wherein A622 is overexpressed.

10. The method of claim 2 , wherein QPT is overexpressed.

11. The method of claim 2 , wherein PMT is overexpressed.

12. The method of claim 2 , wherein MPO is overexpressed.

13. A transgenic Nicotiana plant produced by the method of claim 1 and having an increased alkaloid content as compared to a control plant grown under similar conditions.

14. The transgenic Nicotiana plant of claim 13 , wherein the plant is a Nicotiana tabacum plant.

15. A product having an increased level of a nicotinic alkaloid comprising the transgenic Nicotiana plant of claim 13 , or portions thereof as compared to a product comprising a control plant or portions thereof.

16. Seeds from the transgenic Nicotiana plant of claim 13 , wherein the seeds comprise a vector comprising at least 21 consecutive nucleotides of a nucleotide sequence, wherein the nucleotide sequence is selected from the group consisting of:

(a) the nucleotide sequence set forth in SEQ ID NO: 4; and

(b) a nucleotide sequence that is at least 90% identical to the nucleotide sequence of SEQ ID NO: 4; and

wherein the 21 consecutive nucleotides are in sense orientation, antisense orientation, or both.

17. The product of claim 15 , wherein the product is selected from the group consisting of a cigarette, cigarette tobacco, cigar tobacco, a cigar, pipe tobacco, chewing tobacco, snuff, snus, lozenges, and reconstituted tobacco.

18. The method of claim 1 , wherein the nucleotide sequence consists of the nucleotide sequence set forth in SEQ ID NO: 4.

Assignments (3)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
SECURITY INTEREST Recorded Apr 2, 2015
From: 22ND CENTURY LIMITED, LLC
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 035357/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2015
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 034706/0957 →